Stock SRRK SCHOLAR ROCK HOLDING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Scholar Rock Holding Corporation

Equities

SRRK

US80706P1030

Market Closed - Nasdaq
Other stock markets
 01:30:00 27/04/2024 am IST 		5-day change 1st Jan Change
14.53 USD +4.08% Intraday chart for Scholar Rock Holding Corporation +4.91% -22.71%
28/03 Scholar Rock Shares Rise After Raymond James Initiates Coverage MT
28/03 Raymond James Initiates Scholar Rock With Strong Buy Rating, $30 Price Target MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Scholar Rock Reports New Employee Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Scholar Rock Shares Rise After Raymond James Initiates Coverage
MT
Raymond James Initiates Scholar Rock With Strong Buy Rating, $30 Price Target
MT
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Scholar Rock Reports Full Year 2023 Financial Results and Highlights Business Progress
BU
Scholar Rock Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
North American Morning Briefing : Investors -2-
DJ
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
North American Morning Briefing : Stock Futures -2-
DJ
Scholar Rock : Corporate Presentation March 2024
PU
Scholar Rock to Participate in Upcoming Investor Conferences
BU
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
BU
Scholar Rock Announces Management Appointments
CI
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
BU
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
CI
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
BU
Scholar Rock Says FDA Clears Application for Trial of Obesity Treatment Apitegromab
DJ
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SRRK Stock
  4. News Scholar Rock Holding Corporation